Amgen Inc.
Explore Amgen Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
CorpDigest
Amgen Inc.
Explore Amgen Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
Annual Revenue
FY2023 Revenue
$28.2B
▲ 7.1% vs FY2022 ($26.3B)
Source: Annual report / company filing
Amgen Inc. reported $28.2B in revenue for fiscal year 2023. This represents a growth of 7.1% compared to the 2022 figure of $26.3B. In 2024, revenue increased to $33.4B.
Growth of 7% as newer products and biosimilars gained traction.
| Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $36.8B | — | +10.0% |
| FY2024 | $33.4B | $3.8B | +18.6% |
| FY2023 | $28.2B | — | +7.1% |
| FY2022 | $26.3B | — | +1.3% |
| FY2021 | $26.0B | — | +2.2% |
| FY2020 | $25.4B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.